So for Amarex, the FDA represents the entity it works with for a good portion of its business. For Amarex, Cytodyn is a client. Biggest client, I don’t think so. So the CEO of a medium size client says I want you to give to the entity that reviews your product and to a large part is responsible for your reputation, a shoddy, unready product that does not meet standards. Oh also, you will have to defend this POS to the FDA. And the best documentation Amarex can provide is an unresponded to email. Under these circumstances as founder of a company like Amarex, I would have 100 more emails warning Nadar of the consequences of a poor submission, my documentation of any shortcomings in the submission, my objection to his proposed course, ramifications for CytoDyn and Amarex, alternate proposal to solve the problems, documentation that CytoDyn has acknowledged receipt of these responses and any bad predictions from reading my fortune in Tarot cards. In other words, I protect my butt for when the feces interacts with the ventilator. I have not heard that Amarex has produced this defense.